FDA Issues Complete Response Letter for Libervant
Libervant is a buccally administered soluble film of diazepam used to treat acute uncontrolled seizures in patients with refractory epilepsy on stable AED regimens.
Neurologic Disorders
Elezanumab Granted Orphan Drug, Fast Track Designations for Spinal Cord Injury
Elezanumab is a monoclonal antibody of the human IgG1 isotype that works by binding selectively to repulsive guidance molecule A.
Brain-Eating Amoeba Found in Tap Water of Lake Jackson, Texas
Infection can occur when Naegleria fowleri-contaminated water enters body through the nose.
FDA Requires Boxed Warning Update for Benzodiazepines
Benzodiazepines are widely used to treat a variety of conditions including anxiety disorders, insomnia and seizures.
New Drug Product: Kesimpta
This slideshow shows drug information for Kesimpta. Click here for the complete Kesimpta monograph.
New Drug Application for Apomorphine Infusion Pump Submitted for Review
The NDA for SPN-830 is supported by data from an extensive development program that includes the phase 3 TOLEDO study and a supportive open-label study.
Ongentys Now Available as Add-On Treatment for Parkinson Disease
Ongentys is an oral, selective and reversible inhibitor of catechol-O-methyltransferase.
Florida Teen Dies From Brain-Eating Amoeba
Naegleria fowleri can get into the brain when contaminated water enters the nose.
Sodium Phenylbutyrate-Taurursodiol Promising for ALS
Slower functional decline seen with active drug versus placebo through 24 weeks
Bafiertam Now Available for Relapsing Forms of Multiple Sclerosis
Bafiertam is a novel fumarate bioequivalent alternative to its prodrug dimethyl fumarate.
